phase 2 trial of cv301 vaccine plus atezolizumab in advanced urothelial carcinoma
Published 2 years ago • 29 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
0:50
role of vaccines in urothelial carcinoma
-
1:13
saul analysis: atezolizumab in urothelial carcinoma patients
-
1:40
safety results from phase 3b strong trial of durvalumab in patients with urinary tract carcinoma
-
1:36
liquid biopsies and tumor-informed ctdna profiling in metastatic urothelial carcinoma
-
1:06
key trials in bladder cancer from asco gu 2022
-
4:15
ev-201: enfortumab an option for cisplatin-ineligible advanced uc | arjun balar
-
4:48
neoadjuvant atezolizumab for non-metastatic urothelial cancer
-
19:50
3mensio ct pre-case planning: redo-tavr with prior evolut pro
-
1:14
phase i study of abbv-383, a bcma×cd3 bispecific antibody, in r/r myeloma
-
4:55
new, novel navitor™ tavi valve with active paravalvular leak-sealing technology - europcr 2021
-
46:50
corevalve evolut-r tavr (26mm) via percutaneous femoral access - august 2015 structural live case
-
43:56
transfemoral viv tavr using 23mm evolut pro valve - may 2021
-
1:04:05
transcatheter aortic valve implantation – diagnostic work-up, treatment and post-procedural f/u
-
42:25
corevalve evolut-r tavr (29mm) via percutaneous femoral access - structural heart case - june 2016
-
1:19:24
evolut-r corevalve tavr case utilizing shockwave lithotripsy – september 2019
-
1:00:25
optimal tavi outcomes in the active patient - pcr valves e-course 2020
-
11:26
astellas data from skylight 1™ and skylight 2™ phase 3 trials of fezolinetant for the treatment
-
1:23:59
[ap valves & sh 2022] live case & lecture 2: tavr for bicuspid valve
-
58:10
everything you should know to perform a transcatheter valve in valve procedure - pcr valves e-course